首页 | 本学科首页   官方微博 | 高级检索  
     

循环肿瘤细胞在转移性乳腺癌中的表达及其与多种血清肿瘤标志物的关系
引用本文:钱六七,刘芊,刘毅,张少华,王涛,吴世凯,宋三泰,刘兵,江泽飞. 循环肿瘤细胞在转移性乳腺癌中的表达及其与多种血清肿瘤标志物的关系[J]. 实用肿瘤学杂志, 2012, 26(3): 220-224. DOI: 10.3969/j.issn.1002-3070.2012.03.007
作者姓名:钱六七  刘芊  刘毅  张少华  王涛  吴世凯  宋三泰  刘兵  江泽飞
作者单位:1.安徽医科大学解放军307临床学院乳腺肿瘤科(北京 100071);2.解放军307医院乳腺肿瘤科;3.解放军307医院肿瘤学研究室
摘    要:目的 探讨转移性乳腺癌的循环肿瘤细胞(CTC)和血清肿瘤标志物(CEA、CA153和CA125)的表达水平以及两者之间的相关性。方法 采用CellSearch自动检测系统检测93例转移性乳腺癌患者开始新治疗前的循环肿瘤细胞(CTC),同时采用电化学发光法检测这些患者血清肿瘤标志物(CEA、CA153和CA125)的表达水平。结果 CTC阳性率为60%(56/93),与患者激素受体的状态、Her-2的状态、既往治疗的线数以及内脏转移无关。CEA的阳性率为56%(52/93),ER或PR阳性的患者CEA的阳性率更高(χ2=4.550,P=0.045),与Her-2的状态、既往治疗的线数以及内脏转移无关;CA153的阳性率为47%(44/93),与患者激素受体的状态、Her-2的状态、既往治疗的线数以及内脏转移无关;CA125的阳性率为41%(38/93);既往治疗大于等于二线的患者CA125的阳性率更高(χ2=4.501,P=0.038),与患者激素受体的状态、Her-2的状态以及是否有内脏转移无关。CTC和CEA之间呈正相关(r=0.296,P=0.004);CTC和CA153之间呈正相关(r=0.286,P=0.005);CTCs和CA125两者之间无相关性(r=0.184,P=0.077)。结论 转移性乳腺癌患者的循环肿瘤细胞(CTC)检出率高,而且与血清肿瘤标志物(CEA和CA153)有明显相关性,提示联合检测转移性乳腺癌的循环肿瘤细胞(CTC)和血清肿瘤标志物(CEA和CA153)可能会对其治疗决策有所帮助,同时CTC有可能成为转移性乳腺癌新的治疗靶点。

关 键 词:乳腺肿瘤  循环肿瘤细胞  肿瘤标记物  相关性  电化学发光
收稿时间:2012-02-03

Expression of circulating tumor cells in metastatic breast cancer patients and its relationship with multiple serum tumor markers
QIAN Liuqi , LIU Qian , LIU Yi , ZHANG Shaohua , WANG Tao , WU Shikai , SONG Santai , LIU Bing , JIANG Zefei. Expression of circulating tumor cells in metastatic breast cancer patients and its relationship with multiple serum tumor markers[J]. Journal of Practical Oncology, 2012, 26(3): 220-224. DOI: 10.3969/j.issn.1002-3070.2012.03.007
Authors:QIAN Liuqi    LIU Qian    LIU Yi    ZHANG Shaohua    WANG Tao    WU Shikai    SONG Santai    LIU Bing    JIANG Zefei
Affiliation:1.Department of Breast Cancer,307 Clinic Institute,PLA,Anhui Medical University,Beijing 100071;2.Department of Breast cancer,307 Hospital of PLA;3.Department of Oncology,307 Hospital of PLA
Abstract:Objective To investigate the expression of circulating tumor cells in metastatic breast cancer and its relatonship with CEA,CA153 and CA125. Methods The Cell Search system was used to detect the expressions of CTCs before new line therapy, meanwhile the electroehemiluminescence was used to detect the expression of CEA, C153 and CA125 in 93 patients with metastatic breast cancer. Results 60% (56/93)metastatic breast cancer patients with ≥ 1 CTC/7.5 mL at baseline. The CTC positivity was not correlated with hormone receptor status,Her- 2 status, lines of previous treatment and visceral metastasis. The CEA positivity was 56% ( 52/93 ). It was associated with ER or PR - positive ( X2 = 4.550, P = 0.045 ) , and was not correlated with Her - 2 status ,lines of previous treatment and visceral metastasis. CA153 positivity was 47% (44/93). It was not correlated with hormone receptor status, Her -2 status,lines of previous treatment and visceral metastasis. CA125 positivity was 41% (38/93) , and it was associated with over one- line previous treatment( X2 = 4.501, P = 0. 038 ), However, CA125 positivity was not correlated with hormone receptor status, Her- 2's status and visceral metastasis. The CTC was positively correlated with CEA(r =0. 296,P =0. 004). It was positively correlated with CA153 (r=0.286,P=0.005) ,and not correlated with CA125(r =0. 184,P =0.077). Conclusion The circulatingtumor cells(CTCs) positivity was high in patients with metastatic breast cancer, but also its positivity has correlation with CEA and CA153. Our study indicated that detection of circulating tumor ceils combination with CEA and CA153 in metastatic breast cancer may be helpful for therapy, meanwhile the CTC may become a potential therapy target for metastatic breast cancer.
Keywords:Breast neoplasms  Circulating tumor cells  Tumor markers  Correlation  Electrochemiluminescence
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号